A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
about
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@en
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@nl
type
label
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@en
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@nl
prefLabel
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@en
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@nl
P2093
P2860
P356
P1433
P1476
A Mitochondrial-targeted purine-based HSP90 antagonist for leukemia therapy.
@en
P2093
Andrew V Kossenkov
Dario C Altieri
John C Gordon
Kelly G Bryant
Khaled M Elokely
Magid Abou-Gharbia
Rogelio L Martinez
Steven Grant
Wayne E Childers
Young Chan Chae
P2860
P304
112184-112198
P356
10.18632/ONCOTARGET.23097
P407
P577
2017-12-11T00:00:00Z